{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:04:49Z","timestamp":1787670289086,"version":"build-2736575974"},"reference-count":55,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Although several studies have shown an increased risk of subsequent amyotrophic lateral sclerosis (ALS) diagnosis for individuals with a history of psychiatric disorders, the evidence of an association between use of common psychiatric medications and ALS is scarce and inconclusive.<\/jats:p><\/jats:sec>Objective<\/jats:title>To examine whether there is an association of prescribed use of common psychiatric medications, namely anxiolytics, hypnotics and sedatives, and antidepressants, with the risk and disease progression of ALS.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This nationwide register-based case-control study was conducted in Sweden among all patients diagnosed with ALS from January 1, 2015, to July 1, 2023, according to the Swedish Motor Neuron Disease Quality Registry, who were age- and sex-matched with as many as 5 individuals with no ALS as well as their full siblings and spouses. Patients with ALS were followed up for a median (IQR) of 1.33 (0.64-2.37) years after diagnosis.<\/jats:p><\/jats:sec>Exposures<\/jats:title>At least 2 prescriptions of the studied psychiatric medications before ALS diagnosis.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The risk of ALS diagnosis associated with prediagnostic prescribed use of common psychiatric medications was estimated using conditional logistic regression models, comparing patients with ALS with population or relative control participants. Patients with ALS were followed up from diagnosis to assess the association of prediagnostic prescribed use of common psychiatric medications with disease progression. The association of mortality (or use of invasive ventilation) with the use of common psychiatric medications was estimated with a joint longitudinal-survival model accounting for the longitudinal changes of ALS Functional Rating Scale\u2013Revised (ALSFRS-R) in the time-to-event analysis.<\/jats:p><\/jats:sec>Results<\/jats:title>Among the 1057 case participants and 5281 population control participants, the mean (SD) age at diagnosis of the case participants (ie, date of selection of the control participants) was 67.5 (11.5) years, and 3363 (53.1%) were male. In the population comparison, prescribed use of common psychiatric medications across all studied time windows before ALS diagnosis was associated with a higher risk of ALS (eg, among individuals prescribed hypnotics and sedatives 0-1 year before diagnosis: odds ratio [OR], 6.10; 95% CI, 3.77-9.88; prescribed anxiolytics 1-5 years before diagnosis: OR, 1.60; 95% CI, 1.15-2.23; prescribed antidepressants &amp;gt;5 years before diagnosis: OR, 1.21; 95% CI, 1.02-1.44). Excluding the year before diagnosis from the analysis, prescribed use of anxiolytics (OR, 1.34; 95% CI, 1.12-1.60), hypnotics and sedatives (OR, 1.21; 95% CI, 1.02-1.43), or antidepressants (OR, 1.26; 95% CI, 1.06-1.49) was associated with an increased risk of ALS. Similar results were noted in the comparison with relative control participants, partially alleviating the concern on familial confounding, with the exception of hypnotics and sedatives. Shorter survival was demonstrated among patients with ALS who had prediagnostic use of anxiolytics (hazard ratio [HR], 1.52; 95% CI, 1.12-2.05) or antidepressants (HR, 1.72; 95% CI, 1.30-2.29), compared with patients with ALS without such experience.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this case-control study, prescribed use of anxiolytics, hypnotics and sedatives, or antidepressants was associated with a higher subsequent risk of ALS. Prediagnostic use of such medications was also associated with a poor prognosis after ALS diagnosis.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.14437","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T15:00:43Z","timestamp":1749049243000},"page":"e2514437","source":"Crossref","is-referenced-by-count":3,"title":["Use of Common Psychiatric Medications and Risk and Prognosis of Amyotrophic Lateral Sclerosis"],"prefix":"10.1001","volume":"8","author":[{"given":"Charilaos","family":"Chourpiliadis","sequence":"first","affiliation":[{"name":"Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anik\u00f3","family":"Lovik","sequence":"additional","affiliation":[{"name":"Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden"},{"name":"Institute of Psychology, Leiden University, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Ingre","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Neurology, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayomand","family":"Press","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Neurology, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Samuelsson","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Neurology, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Unnur","family":"Valdimarsdottir","sequence":"additional","affiliation":[{"name":"Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden"},{"name":"Centre of Public Health Sciences, Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland"},{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Fang","sequence":"additional","affiliation":[{"name":"Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"issue":"2","key":"zoi250476r1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1056\/NEJMra1603471","article-title":"Amyotrophic Lateral Sclerosis.","volume":"377","author":"Brown","year":"2017","journal-title":"N Engl J Med"},{"issue":"5","key":"zoi250476r2","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1007\/s00415-024-12219-1","article-title":"Increased incidence of motor neuron disease in Sweden: a population-based study during 2002-2021.","volume":"271","author":"Imrell","year":"2024","journal-title":"J Neurol"},{"issue":"3","key":"zoi250476r3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1136\/jnnp-2019-321737","article-title":"Relationship between neuropsychiatric disorders and cognitive and behavioural change in MND.","volume":"91","author":"McHutchison","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"zoi250476r4","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jad.2021.03.015","article-title":"Prevalence of depression among amyotrophic lateral sclerosis (ALS) patients: a systematic review and meta-analysis.","volume":"287","author":"Heidari","year":"2021","journal-title":"J Affect Disord"},{"issue":"4","key":"zoi250476r5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2165\/00023210-200721040-00003","article-title":"Depression and anxiety in individuals with amyotrophic lateral sclerosis: epidemiology and management.","volume":"21","author":"Kurt","year":"2007","journal-title":"CNS Drugs"},{"key":"zoi250476r6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2023.122780","article-title":"Symptoms of anxiety and depression in patients with amyotrophic lateral sclerosis and their relatives during the disease trajectory.","volume":"455","author":"Larsson","year":"2023","journal-title":"J Neurol Sci"},{"issue":"2","key":"zoi250476r7","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1212\/WNL.0000000000000023","article-title":"Neuropsychiatric changes precede classic motor symptoms in ALS and do not affect survival.","volume":"82","author":"Mioshi","year":"2014","journal-title":"Neurology"},{"issue":"6","key":"zoi250476r8","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1212\/WNL.0000000000004179","article-title":"Neurodegenerative and psychiatric diseases among families with amyotrophic lateral sclerosis.","volume":"89","author":"Longinetti","year":"2017","journal-title":"Neurology"},{"issue":"2","key":"zoi250476r9","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000398","article-title":"ALS in Danish registries: heritability and links to psychiatric and cardiovascular disorders.","volume":"6","author":"Trabjerg","year":"2020","journal-title":"Neurol Genet"},{"issue":"7","key":"zoi250476r10","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1007\/s00415-020-09799-z","article-title":"Impact of comorbidities and co-medication on disease onset and progression in a large German ALS patient group.","volume":"267","author":"Diekmann","year":"2020","journal-title":"J Neurol"},{"issue":"4","key":"zoi250476r11","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/ene.12015","article-title":"Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis.","volume":"20","author":"K\u00f6rner","year":"2013","journal-title":"Eur J Neurol"},{"issue":"24","key":"zoi250476r12","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1212\/WNL.0000000000002671","article-title":"Depression in amyotrophic lateral sclerosis.","volume":"86","author":"Roos","year":"2016","journal-title":"Neurology"},{"issue":"6","key":"zoi250476r13","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/ana.24801","article-title":"Psychiatric disorders prior to amyotrophic lateral sclerosis.","volume":"80","author":"Turner","year":"2016","journal-title":"Ann Neurol"},{"key":"zoi250476r14","doi-asserted-by":"publisher","first-page":"14774","DOI":"10.1038\/ncomms14774","article-title":"Genetic correlation between amyotrophic lateral sclerosis and schizophrenia.","volume":"8","author":"McLaughlin","year":"2017","journal-title":"Nat Commun"},{"issue":"9","key":"zoi250476r15","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1016\/j.celrep.2019.02.006","article-title":"Mutations in the glycosyltransferase domain of GLT8D1 are associated with familial amyotrophic lateral sclerosis.","volume":"26","author":"Cooper-Knock","year":"2019","journal-title":"Cell Rep"},{"issue":"5","key":"zoi250476r16","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/ana.23969","article-title":"Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: a population-based case-control cohort study of familial and sporadic amyotrophic lateral sclerosis.","volume":"74","author":"Byrne","year":"2013","journal-title":"Ann Neurol"},{"issue":"2","key":"zoi250476r17","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1001\/jamainternmed.2016.7507","article-title":"Adult utilization of psychiatric drugs and differences by sex, age, and race.","volume":"177","author":"Moore","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"9","key":"zoi250476r18","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1177\/1403494812459623","article-title":"Prescription drugs: health in Sweden: the National Public Health Report 2012. Chapter 18.","volume":"40","author":"Weitoft","year":"2012","journal-title":"Scand J Public Health"},{"issue":"1","key":"zoi250476r19","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.1998","article-title":"New users of anxiolytics and sedatives in Sweden-Drug type, doses, prescribers\u2019 characteristics, and psychiatric comorbidity in more than 750,000 patients.","volume":"33","author":"Dahl\u00e9n","year":"2024","journal-title":"Int J Methods Psychiatr Res"},{"issue":"1","key":"zoi250476r20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000448618","article-title":"Amyotrophic lateral sclerosis incidence and previous prescriptions of drugs for the nervous system.","volume":"47","author":"D\u2019Ovidio","year":"2016","journal-title":"Neuroepidemiology"},{"key":"zoi250476r21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.pnpbp.2016.06.006","article-title":"Patients receiving lithium therapy have a reduced prevalence of neurological and cardiovascular disorders.","volume":"71","author":"Prosser","year":"2016","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"7-8","key":"zoi250476r22","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1080\/21678421.2018.1497065","article-title":"The Swedish motor neuron disease quality registry.","volume":"19","author":"Longinetti","year":"2018","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"9","key":"zoi250476r23","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/aje\/kwn217","article-title":"What do case-control studies estimate? Survey of methods and assumptions in published case-control research.","volume":"168","author":"Knol","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"2","key":"zoi250476r24","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/ije\/dyr057","article-title":"Commentary: advent of sibling designs.","volume":"40","author":"Donovan","year":"2011","journal-title":"Int J Epidemiol"},{"issue":"7","key":"zoi250476r25","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/pds.1294","article-title":"The new Swedish Prescribed Drug Register\u2014opportunities for pharmacoepidemiological research and experience from the first six months.","volume":"16","author":"Wettermark","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"zoi250476r26","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10654-019-00511-8","article-title":"The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research.","volume":"34","author":"Ludvigsson","year":"2019","journal-title":"Eur J Epidemiol"},{"issue":"9","key":"zoi250476r27","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1136\/jnnp-2019-320553","article-title":"Two heads are better than one: benefits of joint models for ALS trials.","volume":"90","author":"van Eijk","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"zoi250476r28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12874-016-0212-5","article-title":"Joint modelling of time-to-event and multivariate longitudinal outcomes: recent developments and issues.","volume":"16","author":"Hickey","year":"2016","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"zoi250476r29","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/ije\/dyaa260","article-title":"Reflection on modern methods: demystifying robust standard errors for epidemiologists.","volume":"50","author":"Mansournia","year":"2021","journal-title":"Int J Epidemiol"},{"issue":"1","key":"zoi250476r30","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6391686","article-title":"Chronic stress and glucocorticoids: from neuronal plasticity to neurodegeneration.","volume":"2016","author":"Vyas","year":"2016","journal-title":"Neural Plast"},{"issue":"1","key":"zoi250476r31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13041-018-0356-9","article-title":"Early life stress, depression and Parkinson\u2019s disease: a new approach.","volume":"11","author":"Dall\u00e9","year":"2018","journal-title":"Mol Brain"},{"key":"zoi250476r32","doi-asserted-by":"publisher","author":"Gnoni","journal-title":"Front Aging Neurosci","DOI":"10.3389\/fnagi.2023.1193483"},{"issue":"7","key":"zoi250476r33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11910-020-01047-1","article-title":"Sleep and sleep disruption in amyotrophic lateral sclerosis.","volume":"20","author":"Boentert","year":"2020","journal-title":"Curr Neurol Neurosci Rep"},{"key":"zoi250476r34","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.expneurol.2018.07.008","article-title":"Defective daily temperature regulation in a mouse model of amyotrophic lateral sclerosis.","volume":"311","author":"Braun","year":"2019","journal-title":"Exp Neurol"},{"issue":"1","key":"zoi250476r35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s40478-019-0845-9","article-title":"Circadian sleep\/wake-associated cells show dipeptide repeat protein aggregates in C9orf72-related ALS and FTLD cases.","volume":"7","author":"Dedeene","year":"2019","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"zoi250476r36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/17482960601029883","article-title":"Sleep characteristics of amyotrophic lateral sclerosis in patients with preserved diaphragmatic function.","volume":"8","author":"Atalaia","year":"2007","journal-title":"Amyotroph Lateral Scler"},{"key":"zoi250476r37","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104820","article-title":"Impact of sleep disturbances on neurodegeneration: Insight from studies in animal models.","volume":"139","author":"Owen","year":"2020","journal-title":"Neurobiol Dis"},{"issue":"3","key":"zoi250476r38","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/ane.12869","article-title":"Late age onset of amyotrophic lateral sclerosis is often not considered in elderly people.","volume":"137","author":"Broussalis","year":"2018","journal-title":"Acta Neurol Scand"},{"issue":"1-2","key":"zoi250476r39","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1080\/21678421.2023.2260808","article-title":"Misdiagnosis of amyotrophic lateral sclerosis in clinical practice in Europe and the USA: a patient chart review and physician survey.","volume":"25","author":"Goyal","year":"2024","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"6","key":"zoi250476r40","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2188\/jea.JE20190042","article-title":"Help-seeking behavior and psychological distress by age in a nationally representative sample of Japanese employees.","volume":"30","author":"Yamauchi","year":"2020","journal-title":"J Epidemiol"},{"issue":"12","key":"zoi250476r41","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1097\/JGP.0b013e31818cd3be","article-title":"Older adults\u2019 help-seeking attitudes and treatment beliefs concerning mental health problems.","volume":"16","author":"Mackenzie","year":"2008","journal-title":"Am J Geriatr Psychiatry"},{"key":"zoi250476r42","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.712112","article-title":"Disparities in utilization of psychiatry services among home care clients: the tale of two Canadian jurisdictions.","volume":"12","author":"Poss","year":"2021","journal-title":"Front Psychiatry"},{"key":"zoi250476r43","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3389\/fneur.2019.00192","article-title":"The impact of cognitive and behavioral symptoms on ALS Patients and their caregivers.","volume":"10","author":"Caga","year":"2019","journal-title":"Front Neurol"},{"issue":"9","key":"zoi250476r44","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.parkreldis.2010.06.014","article-title":"Occurrence of depression and anxiety prior to Parkinson\u2019s disease.","volume":"16","author":"Jacob","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"zoi250476r45","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/YCO.0000000000000050","article-title":"Neuropsychiatric symptoms in the prodromal stages of dementia.","volume":"27","author":"Stella","year":"2014","journal-title":"Curr Opin Psychiatry"},{"issue":"1","key":"zoi250476r46","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41398-024-02739-9","article-title":"Association of amyloid-beta with depression or depressive symptoms in older adults without dementia: a systematic review and meta-analysis.","volume":"14","author":"Twait","year":"2024","journal-title":"Transl Psychiatry"},{"issue":"12","key":"zoi250476r47","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-008853","article-title":"Dementia risk estimates associated with measures of depression: a systematic review and meta-analysis.","volume":"5","author":"Cherbuin","year":"2015","journal-title":"BMJ Open"},{"issue":"7","key":"zoi250476r48","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/S2215-0366(16)00097-3","article-title":"10-Year trajectories of depressive symptoms and risk of dementia: a population-based study.","volume":"3","author":"Mirza","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"7","key":"zoi250476r49","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1001\/jamapsychiatry.2017.0660","article-title":"Trajectories of depressive symptoms before diagnosis of dementia: a 28-year follow-up study.","volume":"74","author":"Singh-Manoux","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"18","key":"zoi250476r51","doi-asserted-by":"publisher","first-page":"6546","DOI":"10.3390\/ijms21186546","article-title":"Neuroinflammation-associated alterations of the brain as potential neural biomarkers in anxiety disorders.","volume":"21","author":"Won","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"11","key":"zoi250476r52","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.jagp.2019.05.019","article-title":"Exposure to antidepressant medication and the risk of incident dementia.","volume":"27","author":"Kodesh","year":"2019","journal-title":"Am J Geriatr Psychiatry"},{"issue":"236","key":"zoi250476r53","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3008169","article-title":"An antidepressant decreases CSF A\u00df production in healthy individuals and in transgenic AD mice.","volume":"6","author":"Sheline","year":"2014","journal-title":"Sci Transl Med"},{"issue":"3","key":"zoi250476r54","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1176\/appi.ajp.2017.17040404","article-title":"Impact of SSRI therapy on risk of conversion from mild cognitive impairment to Alzheimer\u2019s dementia in individuals with previous depression.","volume":"175","author":"Bartels","year":"2018","journal-title":"Am J Psychiatry"},{"issue":"1","key":"zoi250476r55","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.1212\/WNL.0000000000011093","article-title":"Differential neuropsychological profile of patients with amyotrophic lateral sclerosis with and without C9orf72 mutation.","volume":"96","author":"Iazzolino","year":"2021","journal-title":"Neurology"},{"key":"zoi250476r50","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/978-1-4614-5836-4_176","volume-title":"Handbook of Neurotoxicity","author":"Smaga","year":"2014"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2834877\/chourpiliadis_2025_oi_250476_1748437525.66432.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T15:00:44Z","timestamp":1749049244000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2834877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.14437","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]}}}